Éloi R. Verrier
- Epidemiology top 10%
- Hepatology top 2%
- Immunology top 10%
- Infectious Diseases top 10%
- Molecular Biology
- Co-authors
- Thomas F. BaumertChristelle LangevinPierre BoudinotChe C. ColpittsCatherine SchusterAbdenour BenmansourMirjam B. ZeiselGaëtan Ligat
- Topics
- Hepatitis B Virus Studies (31 papers)Hepatitis C virus research (28 papers)Liver Disease Diagnosis and Treatment (15 papers)
- Cited by
- HepatologyImmunologyEpidemiology
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Éloi R. Verrier
39 papers receiving 738 citations
Peers
Comparison fields: 5 of 65
- Epidemiology 386
- Hepatology 308
- Immunology 272
- Infectious Diseases 162
- Molecular Biology 148
Countries citing papers authored by Éloi R. Verrier
This map shows the geographic impact of Éloi R. Verrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éloi R. Verrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éloi R. Verrier more than expected).
Fields of papers citing papers by Éloi R. Verrier
This network shows the impact of papers produced by Éloi R. Verrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éloi R. Verrier. The network helps show where Éloi R. Verrier may publish in the future.
Co-authorship network of co-authors of Éloi R. Verrier
This figure shows the co-authorship network connecting the top 25 collaborators of Éloi R. Verrier. A scholar is included among the top collaborators of Éloi R. Verrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éloi R. Verrier. Éloi R. Verrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method | 12 |
| 6 | 3 | |
| 7 | 0 | |
| 8 | 27 | |
| 9 | 14 | |
| 10 | 16 | |
| 11 | 16 | |
| 12 | 0 | |
| 13 | 6 | |
| 14 | 0 | |
| 15 | 18 | |
| 16 | 35 | |
| 17 | 18 | |
| 18 | 8 | |
| 19 | 36 | |
| 20 | 98 |
About Éloi R. Verrier
Éloi R. Verrier is a scholar working on Hepatology, Epidemiology and Animal Science and Zoology, having authored 46 papers that have together received 748 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (31 papers), Hepatitis C virus research (28 papers) and Liver Disease Diagnosis and Treatment (15 papers). The work is most often cited by research in Hepatology (308 citations), Immunology (272 citations) and Epidemiology (386 citations). Éloi R. Verrier has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Thomas F. Baumert, Christelle Langevin, Pierre Boudinot, Che C. Colpitts, Catherine Schuster, Abdenour Benmansour, Mirjam B. Zeisel, Gaëtan Ligat, Thomas F. Baumert and Laura Heydmann. Their work appears in journals such as PLoS ONE, Hepatology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.